Background Image
Table of Contents Table of Contents
Previous Page  42 / 62 Next Page
Information
Show Menu
Previous Page 42 / 62 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 1, January/February 2020

40

AFRICA

Echocardiographic left atrial remodelling and determinants

of left atrial size in the early phase of high blood pressure:

a comparative cross-sectional study in Douala, Cameroon

Armelle Corrine Simo Gounoue, Anastase Dzudie Tamdja, Simeon-Pierre Choukem, Hamadou Ba,

Sidick Mouliom Aboubakar, Archange Nzali, Marie Patrice Halle, Clovis Nkoke, Benjamin Momo Kadia,

Martin Hongieh Abanda, Chris Nadege Nganou, Marcel Kenfack Abzabji, Samuel Kingue

Abstract

Background:

Left atrial remodelling (LAR) has been described

in Western populations with chronic hypertension and is asso-

ciated with a higher risk of adverse cardiovascular events.

Although hypertension tends to occur earlier and is more

severe in sub-Saharan Africa than in more developed nations,

LAR and its associated factors in these African hypertensive

subjects have been poorly elucidated.

Objectives:

To assess left atrial structural remodelling in black

hypertensive patients and determine factors associated with

left atrial size.

Methods:

This was a cross-sectional, comparative study

carried out in two tertiary hospitals in Douala, Cameroon

over a period of three months. Fifty-two patients, either newly

diagnosed with hypertension or known hypertensives treated

for less than a year, were consecutively recruited. These

patients were matched (unpaired matching) for age and

gender to 40 randomly selected healthy subjects. The poste-

rior–anterior diameter indexed to body surface area (BSA),

volume indexed to BSA, and longitudinal and transverse

diameters of the left atrium (LA) were measured using trans-

thoracic echocardiography, in accordance with the American

Society of Echocardiography guidelines. LAR was defined

as increase in LA size, characterised by LA volume

34 ml/

m

2

. Early morning urine was analysed for microalbuminuria

using urine strips to obtain spot albumin/creatinine ratio.

Data were analysed using SPSS version 23 and statistical

significance was set at

p

<

0.05.

Results:

The gender distribution and mean age were similar

between the two groups. Hypertensive patients had signifi-

cantly higher mean body mass index, left ventricular mass

and an altered diastolic function. They also had significantly

higher LA longitudinal diameter (50.0 vs 47.4 mm;

p

=

0.045),

surface area (17.9 vs 15.5 cm

2

;

p

=

0.003) and volume (52.4

vs 43.8 ml;

p

=

0.002) compared to the non-hypertensive

counterparts. Fourteen patients (26.9%) had LA enlargement

compared to one (2.5%) in the non-hypertensive group (odds

ratio

=

9.78, CI: 2.67–35.8,

p

<

0.0001). Diastolic dysfunction

(

p

=

0.008) was the only independent predictor of LA size in

the hypertensive subjects. Microalbuminuria did not signifi-

cantly correlate with LA size.

Conclusion:

Our study shows evidence of LAR in newly diag-

nosed black African patients with hypertension, characterised

by an increase in the LA length, surface area and volume.

Future studies are warranted to better elucidate the biological

mechanisms underlying the link between the early phase of

hypertension and LAR, as well as its prognostic implications

in our population.

Keywords:

hypertension, left atrium, remodelling, SSA

Submitted 11/1/19, accepted 31/7/19

Published online 9/9//19

Cardiovasc J Afr

2020;

31

: 40–46

www.cvja.co.za

DOI: 10.5830/CVJA-2019-046

Hypertension is an important public health challenge worldwide.

1

In sub-Saharan African populations, hypertension tends to occur

at an earlier age than in more developed nations, is frequently

under-diagnosed, and is often severe and complicated at the time

of diagnosis.

2-4

Faculty of Health Sciences, University of Buea, Buea,

Cameroon

Armelle Corrine Simo Gounoue, MD,

corrine_simo@yahoo.com

Anastase Dzudie Tamdja, MD, PhD, FESC

Simeon-Pierre Choukem, MD, PU-PH (Paris)

Faculty of Medicine and Biomedical Sciences, University

of Yaoundé I, Yaoundé, Cameroon

Anastase Dzudie Tamdja, MD, PhD, FESC

Hamadou Ba, MD

Chris Nadege Nganou, MD

Marcel Kenfack Abzabji, MD

Samuel Kingue, MD

Douala General Hospital, Douala, Cameroon

Anastase Dzudie Tamdja, MD, PhD, FESC

Simeon-Pierre Choukem, MD, PU-PH (Paris)

Sidick Mouliom Aboubakar, MD

Marie Patrice Halle, MD, DU, DES (Nephology)

Clinical Research Education, Networking and Consultancy,

Douala, Cameroon

Anastase Dzudie Tamdja, MD, PhD, FESC

Archange Nzali, MD, DU (Cardiology)

Armelle Corrine Simo Gounoue, MD,

corrine_simo@yahoo.com

Martin Hongieh Abanda, MD

Deido District Hospital, Douala, Cameroon

Archange Nzali, MD, DU (Cardiology)

Buea Regional Hospital, Buea, Cameroon

Clovis Nkoke, MD

Faculty of Epidemiology and Population Health and Centre

for Evaluation, London School of Hygiene and Tropical

Medicine, London, UK

Benjamin Momo Kadia, MD